Homozygous Familial Hypercholesterolemia and Its Management

Seminars in Vascular Medicine

Volumn 4, Issue 1, 2004, Pages 43-50

  Marais, Adrian David ^a   Firth, Jean Catherine ^a   Blom, Dirk Jacobus ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Homozygous familial hypercholesterolemia; Low density lipoprotein, plasmapheresis; Statins

Indexed keywords

ANTILIPEMIC AGENT; COLESTYRAMINE; EZETIMIBE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; AGED; AORTA ATHEROSCLEROSIS; AORTA VALVE; CLINICAL FEATURE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FAMILIAL HYPERCHOLESTEROLEMIA; GENE MUTATION; GENE THERAPY; GRAFT REJECTION; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART TRANSPLANTATION; HOMOZYGOSITY; HUMAN; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA TYPE 2; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; PLASMAPHERESIS; PORTOCAVAL SHUNT; RECEPTOR GENE; REVIEW; TREATMENT INDICATION;

BIOLOGICAL MARKERS; DISEASE MANAGEMENT; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II;

EID: 1642384095     PISSN: 15289648     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-822985     Document Type: Review

References (64)

1. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986;232:34-47
2. James RW, Martin B, Pometta D, et al. Apolipoprotein B metabolism in homozygous familial hypercholesterolemia. J Lipid Res 1989;30:159-169
3. Rubinsztein DC, Cohen JC, Berger GM, et al. Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects. J Clin Invest 1990;86:1306-1312
4. Watts GF, Barrett PH, Marais AD, et al. Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test. Atherosclerosis 2001;157: 519-523
5. Mamo JC, Bowler A, Elsegood CL, Redgrave TG. Defective plasma clearance of chylomicron-like lipid emulsions in Watanabe heritable hyperlipidemic rabbits. Biochim Biophys Acta 1991;1081:241-245
6. Moorjani S, Roy M, Torres A, et al. Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolaemia. Lancet 1993;341: 1303-1306
7. Napoli C, Postiglione A, Triggiani M, et al. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia. Atherosclerosis 1995; 118:259-273
8. Napoli C, Postiglione A, Scarpato N, et al. LDL oxidation in homozygous familial hypercholesterolemia: effects of selective LDL-apheresis treatment. Cardiologia 1996;41(5):435-439
9. Aviram M, Fuhrman B, Boulos M, Ginsburg H, Brook JG. Effect of plasma lipoproteins on cholesterol accumulation in macrophages: comparison of lipoproteins from normal and homozygous familial hypercholesterolemic subjects. Atherosclerosis 1987;65:207-214
10. Goldberg RB, Fless GM, Baker SG, et al. Abnormalities of high density lipoproteins in homozygous familial hypercholesterolemia. Arteriosclerosis 1984;4:472-478
11. Keidar S, Ostlund RE Jr, Schonfeld G. Apolipoprotein E-rich HDL in patients with homozygous familial hypercholesterolemia. Atherosclerosis 1990;84:155-163
12. Schaefer JR, Rader DJ, Ikewaki K, et al. In vivo metabolism of apolipoprotein A-I in a patient with homozygous familial hypercholesterolemia. Arterioscler Thromb 1992;12:843-848
13. Rader DJ, Mann WA, Cain W, et al. The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans. J Clin Invest 1995;95:1403-1408
14. Guo HC, Chapman MJ, Bruckert E, Farriaux JP, De Gennes JL. Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype. Atherosclerosis 1991;86:69-83
15. Kraft HG, Lingenhel A, Raal FJ, Hohenegger M, Utermann G. Lipoprotein(a) in homozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2000;20:522-528
16. Krempler F, Kostner GM, Roscher A, et al. Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man. J Clin Invest 1983;71:1431-1441
17. Atkinson JB, Stacpoole PW, Swift LL. Morphologic abnormalities of erythrocytes from patients with homozygous familial hypercholesterolemia. Biochim Biophys Acta 1982; 712:211-216
18. Illingworth DR, Alam NA, Lindsey S. Adrenocortical response to adrenocorticotropin in heterozygous familial hypercholesterolemia. J Clin Endocrinol Metab 1984;58: 206-211
19. Boizel R, de Peretti E, Cathiard AM, et al. Pattern of plasma levels of cortisol, dehydroepiandrosterone and pregnenolone sulphate in normal subjects and in patients with homozygous familial hypercholesterolaemia during ACTH infusion. Clin Endocrinol 1986;25:363-371
20. Buja LM, Kovanen PT, Bilheimer DW. Cellular pathology of homozygous familial hypercholesterolemia. Am J Pathol 1979;97:327-357
21. Marais AD, Firth JC, Rose AG, Berger GM. Fatal outcome of homozygous familial hypercholesterolaemia in a black patient. A case report. S Afr Med J 1990;77:588-590
22. Stehbens WE, Martin M. The vascular pathology of familial hypercholesterolemia. Pathology 1991;23:54-61
23. Summers RM, Andrasko-Bourgeois J, Feuerstein IM, et al. Evaluation of the aortic root by MRI: insights from patients with homozygous familial hypercholesterolemia. Circulation 1998;98:509-518
24. Summers RM, Choyke PL, Patronas NJ, et al. MR virtual angioscopy of thoracic aortic atherosclerosis in homozygous familial hypercholesterolemia. J Comput Assist Tomogr 2001;25:371-377
25. Bertolini S, Cassanelli S, Garuti R, et al. Analysis of LDL receptor gene mutations in Italian patients with homozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 1999;19:408-418
26. Haitas B, Baker SG, Meyer TE, Joffe BI, Seftel HC. Natural history and cardiac manifestations of homozygous familial hypercholesterolaemia. QJ Med 1990;76:731-740
27. Kawaguchi A, Miyatake K, Yutani C, et al. Characteristic cardiovascular manifestation in homozygous and heterozygous familial hypercholesterolemia. Am Heart J 1999;137: 410-418
28. Khachadurian AK, Uthman SM. Experiences with the homozygous cases of familial hypercholesterolemia. A report of 52 patients. Nutr Metab 1973;15:132-140
29. Moorjani S, Roy M, Gagne C, et al. Homozygous familial hypercholesterolemia among French Canadians in Quebec Province. Arteriosclerosis 1989;9:211-216
30. Sprecher DL, Schaefer EJ, Kent KM, et al. Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients. Am J Cardiol 1984;54:20-30
31. Norman D, Sun X, Bourbon M, et al. Characterization of a novel cellular defect in patients with phenotypic homozygous hypercholesterolaemia. J Clin Invest 1999;104:619-628
32. Thompson GR, Miller JP, Breslow JL. Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange. BMJ 1985;291:1671-1673
33. Yamashita S, Ueyama Y, Funahashi T, et al. A 31-year-old woman with homozygous familial hypercholesterolemia without significant lesions in the coronary arteries. Atherosclerosis 1986;62:117-121
34. Jaeger BR, Tsobanelis T, Bengel F, Schwaiger M, Seidel D. Long-term prevention of premature coronary atherosclerosis in homozygous familial hypercholesterolemia. J Pediatr 2002;141:125-128
35. Yasuda T, Kawasuji M, Sakakibara N, Watanabe Y. Aortic valve replacement for the calcified ascending aorta in homozygous familial hypercholesterolemia. Eur J Cardiothorac Surg 2000;18:249-250
36. Raal FJ, Pilcher GJ, Waisberg R, et al. Low-density lipoprotein cholesterol bulk is the pivotal determinant of atherosclerosis in familial hypercholesterolemia. Am J Cardiol 1999;83:1330-1333
37. Schmidt HH, Hill S, Makariou EV, et al. Relation of cholesterol-year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemia. Am J Cardiol 1996;77:575-580.
38. Vergotine J, Thiart R, Langenhoven E, et al. Prenatal diagnosis of familial hypercholesterolemia: importance of DNA analysis in the high-risk South African population. Genet Couns 2001;12:121-127
39. Beigel Y, Bar J, Cohen M, Hod M. Pregnancy outcome in familial homozygous hypercholesterolemic females treated with long-term plasma exchange. Acta Obstet Gynecol Scand 1998;77:603-608
40. Teruel JL, Lasuncion MA, Navarro JF, Carrero P, Ortuno J. Pregnancy in a patient with homozygous familial hypercholesterolemia undergoing low-density lipoprotein apheresis by dextran sulfate adsorption. Metabolism 1995;44:929-933
41. Kroon AA, Swinkels DW, van Dongen PW, Stalenhoef AF. Pregnancy in a patient with homozygous familial hypercholesterolemia treated with long-term low-density lipoprotein apheresis. Metabolism 1994;43:1164-1170
42. Marais AD, Blom DJ, Firth JC. Statins in homozygous familial hypercholesterolemia. Curr Atheroscler Rep 2002;4: 19-25
43. Raal FJ, Pilcher GJ, Illingworth DR, et al. Expanded-dose simvastatin is effective in homozygous familial hypercholesterolaemia. Atherosclerosis 1997;135:249-256
44. Raal FJ, Pappu AS, Illingworth DR, et al. Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia. Atherosclerosis 2000;150:421-428
45. Marais AD, Wood L, Firth JC, Hall JM, Jacobs P. Plasma exchange for homozygous familial hypercholesterolaemia: the Cape Town experience. Transfus Sci 1993;14:239-247
46. Marais AD, Naoumova RP, Firth JC, et al. Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia. J Lipid Res 1997;38:2071-2078
47. Gagne C, Gaudet D, Bruckert E. Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia. Circulation 2002;105:2469-2475
48. Baker SG, Joffe BI, Mendelsohn D, Seftel HC. Treatment of homozygous familial hypercholesterolaemia with probucol. S Afr Med J 1982;62:7-11
49. Yamamoto A, Matsuzawa Y, Kishino B, Hayashi R, Kikkawa T. Effects of Probucol on Homozygous Cases of Familial Hypercholesterolaemia. Atherosclerosis 1983;48: 157-166
50. Wetterau JR, Gregg RE, Harrity TW, et al. An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits. Science 1998;282:751-754
51. Amano Y, Nishimoto T, Tozawa R, et al. Lipid-lowering effects of TAK-475, a squalene synthase inhibitor, in animal models of familial hypercholesterolemia. Eur J Pharmacol 2003;466:155-161
52. Thompson GR. LDL apheresis. Atherosclerosis 2003;167:1-13
53. Stefanutti C, Vivenzio A, Colombo C, et al. Treatment of homozygous and double heterozygous familial hypercholesterolemic children with LDL-apheresis. Int J Artif Organs 1995;18:103-110
54. Keller C, Schmitz H, Theisen K, Zollner N. Regression of valvular aortic stenosis due to homozygous familial hypercholesterolemia following plasmapheresis. Klin Wochenschr 1986;64:338-341
55. Forman MB, Baker SG, Mieny CJ, et al. Treatment of homozygous familial hypercholesterolaemia with portacaval shunt. Atherosclerosis 1982;41:349-361
56. Bilheimer DW, Goldstein JL, Grundy SM, Brown MS. Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia. J Clin Invest 1975;56:1420-1430
57. Hoeg JM, Demosky SJ Jr, Schaefer EJ, et al. The effect of portacaval shunt on hepatic lipoprotein metabolism in familial hypercholesterolemia. J Surg Res 1985;39:369-377
58. McNamara DJ, Ahrens EH Jr, Kolb R, et al. Treatment of familial hypercholesterolemia by portacaval anastomosis: effect on cholesterol metabolism and pool sizes. Proc Natl Acad Sci USA 1983;80:564-568
59. Starzl TE, Chase P, Ahrens EH, et al. Portocaval shunt in patients with familial hypercholesterolemia. Ann Surg 1983;198:273-283
60. Bilheimer DW, Goldstein JL, Grundy SM, Starzl TE, Brown MS. Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med 1984;311:1658-1664
61. Revell SP, Noble-Jamieson G, Johnston P, et al. Liver transplantation for homozygous familial hypercholesterolaemia. Arch Dis Child 1995;73:456-458
62. Lopez-Santamaria M, Migliazza L, Gamez M, et al. Liver transplantation in patients with homozygotic familial hypercholesterolemia previously treated by end-to-side portocaval shunt and ileal bypass. J Pediatr Surg 2000;35(4):630-633
63. Grossman M, Rader DJ, Muller DW, et al. A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med 1995;1:1148-1154
64. Rader DJ, Tietge UJ. Gene therapy for dyslipidemia: clinical prospects. Curr Atheroscler Rep 1999;1:58-69